Roche's Tecentriq/Avastin combo wins US approval
admin 3rd June 2020 Uncategorised 0Tecentriq in combination with Avastin is the first and only cancer immunotherapy regimen cleared to treat unresectable or metastatic liver cancer
More: Roche's Tecentriq/Avastin combo wins US approval
Source: News